tiprankstipranks
Ocumension Therapeutics (HK:1477)
:1477
Hong Kong Market
1477
Ocumension Therapeutics
RESEARCH TOOLSreports
Want to see HK:1477 full AI Analyst Report?

Ocumension Therapeutics (1477) Income Statement

1 Followers

Ocumension Therapeutics Income Statement

Last quarter (Q2 2025), Ocumension Therapeutics's total revenue was ¥294.03M, an increase of 183.55% from the same quarter last year. In Q2, Ocumension Therapeutics's net income was ¥-132.32M. See Ocumension Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 783.53M¥ 417.31M¥ 246.37M¥ 158.96M¥ 56.15M
Gross Profit
¥ 343.08M¥ 225.06M¥ 144.37M¥ 102.92M¥ 36.94M
Operating Expenses
¥ 499.14M¥ 529.14M¥ 546.51M¥ 558.78M¥ 422.48M
Depreciation and Amortization
¥ 8.50M¥ 77.07M¥ 57.54M¥ 40.46M¥ 9.62M
EBITDA
¥ -147.56M¥ -188.03M¥ -320.62M¥ -359.98M¥ -249.81M
Operating Income
¥ -156.06M¥ -306.43M¥ -402.15M¥ -455.86M¥ -385.20M
Other Income/Expenses
¥ 1.69M¥ 39.17M¥ 21.86M¥ 53.63M¥ 125.55M
Pretax Income
¥ -154.37M¥ -267.26M¥ -379.48M¥ -402.23M¥ -259.99M
Net Income
¥ -154.71M¥ -268.27M¥ -379.79M¥ -402.64M¥ -259.99M
Per Share Metrics
Basic EPS
¥ -0.20¥ -0.39¥ -0.59¥ -0.64¥ -0.43
Diluted EPS
¥ -0.20¥ -0.39¥ -0.59¥ -0.64¥ -0.43
Weighted Average Shares Outstanding
 794.12M 687.88M 649.19M 632.53M 607.14M
Weighted Average Shares Outstanding (Diluted)
 794.12M 687.88M 649.19M 632.53M 607.14M
Currency in CNY

Ocumension Therapeutics Earnings and Revenue History